Risk of incident atrial fibrillation in gout: a cohort study

Seoyoung C Kim1, Jun Liu2, Daniel H Solomon1

  • 1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Insights

Gout patients have a modestly increased risk of developing atrial fibrillation (AF). This study found a higher incidence of AF in gout patients compared to those with osteoarthritis or no gout.

Area of Science:

  • Cardiology
  • Rheumatology
  • Epidemiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia linked to cardiovascular disease and mortality.
  • Emerging evidence suggests a connection between inflammation, hyperuricemia, and AF.
  • The specific risk of AF in patients with gout remains largely unexplored.

Purpose of the Study:

  • To investigate the association between gout and the risk of incident atrial fibrillation.
  • To compare AF risk in patients with gout versus osteoarthritis.
  • To evaluate AF risk in gout patients compared to a non-gout population.

Main Methods:

  • A cohort study utilizing US commercial insurance data from 2004-2013.
  • Identified patients with gout or osteoarthritis based on diagnoses and medication use.
  • Defined incident AF by new diagnosis and new medication dispensing; compared AF risk across groups.

Main Results:

  • The study included 70,015 patients with gout and 210,045 with osteoarthritis.
  • Gout patients showed a higher incidence rate of AF (7.19 per 1000 person-years) compared to osteoarthritis patients (5.87).
  • Gout was associated with a modestly increased risk of incident AF (HR 1.13-1.21) after adjusting for confounders.

Conclusions:

  • Gout is associated with a modestly increased risk of incident atrial fibrillation.
  • This association persists after accounting for other cardiovascular risk factors and comorbidities.
  • Findings highlight a potential link between gout and AF, warranting further investigation.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
494
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
886
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
455
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
500